Moderna
MRNA
#290
Rank
โ‚น7.339 T
Marketcap
โ‚น18,140
Share price
-1.79%
Change (1 day)
747.82%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚น389.17 Billion

According to Moderna 's latest financial reports the company's total liabilities are โ‚น389.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น331.06 B19.08%
2024-12-31โ‚น278.03 B-26.95%
2023-12-31โ‚น380.61 B-31.71%
2022-12-31โ‚น557.32 B-28.85%
2021-12-31โ‚น783.31 B124.26%
2020-12-31โ‚น349.28 B1081.37%
2019-12-31โ‚น29.56 B-2.1%
2018-12-31โ‚น30.20 B3%
2017-12-31โ‚น29.31 B-25%
2016-12-31โ‚น39.09 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚น10.738 T 2,659.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น7.374 T 1,794.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น8.137 T 1,990.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚น0.53 B-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น4.06 B-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น406.85 B 4.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น152.51 B-60.81%๐Ÿ‡บ๐Ÿ‡ธ USA